ID   BL-50
AC   CVCL_IV15
SY   BL50; BL 50; IARC/BL50; IARC/BL 50; IARC-BL50; IARC BL50; IARC BL 50
DR   Wikidata; Q54797213
RX   PubMed=3035497;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C150 ! BL-49
OI   CVCL_VQ26 ! IARC-208
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
RX   PubMed=3035497; DOI=10.1093/nar/15.11.4553; PMCID=PMC340879;
RA   Szajnert M.-F., Saule S., Bornkamm G.-W., Wajcman H., Lenoir G.M.,
RA   Kaplan J.-C.;
RT   "Clustered somatic mutations in and around first exon of
RT   non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation.";
RL   Nucleic Acids Res. 15:4553-4565(1987).
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//